FDA seizes generic drugs at Michigan facilities due to manufacturing deficiencies.
Bloomberg News (6/26, Olmos) reports, “Generic drugs made by Caraco Pharmaceutical Laboratories Ltd. were seized by US authorities, who cited violations of manufacturing standards.” The FDA said drugs “and raw ingredients for pain, heart ailment, and psychiatric medications were confiscated today at three Caraco facilities in Michigan to prevent the Detroit-based company from distributing its products until the manufacturing deficiencies are corrected.” The agency also said the “drug seizure could lead to shortages of one pill, choline magnesium trisalicylate, a generic pain-relief medication.” Deborah Autor, director of the Office of Compliance at the FDA’s Center for Drug Evaluation and Research, said inspectors who saw the facilities in May 2009 “found ‘serious violations’ of manufacturing standards and ‘serious deficiencies’ in quality control.”

This entry was posted on Friday, June 26th, 2009 at 2:29 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.